Mental Health Care Access Varies Across Demographics, Insurance Coverage

One in four adults reported symptoms of anxiety and/or depression prior to the COVID-pandemic, according to a Kaiser Family Foundation analysis of the National Health Interview Survey in 2019. While the rates of people reporting mental health symptoms across racial and ethnic groups are similar, a much larger share of Black adults with moderate to severe symptoms did not receive treatment. Meanwhile, uninsured people were significantly more likely to not receive mental health care (62%) compared to their insured counterparts (36%). Since the pandemic began, more people suffered from poor mental health, with one-third of adults reporting anxiety and/or depressive disorder in February 2022.

mental-health-care-access-varies

NOTES: Moderate symptoms of anxiety and/or depression refers to a score of 10 to 14 on the GAD-7 scale and/or PHQ-8 scale; severe symptoms refers to a score of 15 or higher.

SOURCE: “How Does Use of Mental Health Care Vary by Demographics and Health Insurance Coverage?” Kaiser Family Foundation.

This infographic was reprinted from AIS Health’s weekly publication Health Plan Weekly.

© 2024 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong has been producing infographics and data stories on employer-sponsored insurance, public health insurance programs and prescription drug coverage for AIS Health’s Health Plan Weekly and Radar on Drug Benefits since 2018. She also manages AIS Health’s annual executive compensation database for top insurers and Blue Cross and Blue Shield affiliates. Before joining AIS Health, she interned at WBEZ, Al Jazeera English and The New York Times Chinese. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting.

Related Posts

call-center
June 20

With IRA Impacts Looming, Manufacturers Should Focus on Providing Patient Support

Read More
drug
June 20

FDA Moves Bring Total Biosimilar Approvals to 53

Read More
pills-and-bills
June 20

Report: Led by Anti-Inflammatories, Specialty Drugs Continue Upward Trend

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today